Sedivention

Munchen, Germany Founded: 2021 • Age: 5 yrs
Developer of a minimally invasive cryo-ablation therapy for obesity. This outpatient procedure uses cryo-ablation technology to disrupt the gastric branches of the vagus nerve, permanently reducing hunger feelings. A medical device has been developed and successfully tested for safety and efficacy. The therapy aims to provide a long-term solution for weight loss, addressing a significant unmet medical need. The company is supported by several awards and investments.
Request Access

About Sedivention

Sedivention is a company based in Munchen (Germany) founded in 2021 by Ute Nollert.. Sedivention has raised $843.06 thousand across 1 funding round from investors including High-Tech Gründerfonds. Sedivention offers products and services including Blizzard Catheter. Sedivention operates in a competitive market with competitors including Allurion, Apollo Endo, GT Metabolic Solutions, IG Balloon and Spatz FGIA, among others.

  • Headquarter Munchen, Germany
  • Founders Ute Nollert
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Sedivention Gmbh
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $843.06 K (USD)

    in 1 rounds

  • Latest Funding Round
    $843.06 K (USD), Seed

    Nov 18, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Sedivention

Sedivention offers a comprehensive portfolio of products and services, including Blizzard Catheter. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Performs cryo-ablation to reduce hunger feeling for long-term obesity management.

Funding Insights of Sedivention

Sedivention has successfully raised a total of $843.06K through 1 strategic funding round. The most recent funding activity was a Seed round of $843.06 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $843,064
  • First Round

    (18 Nov 2024)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2024 Amount Seed - Sedivention Valuation HTGF
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Sedivention

Sedivention has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include High-Tech Gründerfonds. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage investments are made in high-tech startups by HTGF.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Sedivention

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Sedivention

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Sedivention Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Sedivention

Sedivention operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Allurion, Apollo Endo, GT Metabolic Solutions, IG Balloon and Spatz FGIA, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Satiety induction through digestable gastric balloon introduced via a swallowed capsule
domain founded_year HQ Location
Therapeutic devices for obesity and GI disorders are developed.
domain founded_year HQ Location
Incision-less bariatric surgery technology is developed for gastric bypass.
domain founded_year HQ Location
Offers updates on medical device designs and clinical trial outcomes.
domain founded_year HQ Location
Minimally invasive gastric balloon is developed for obesity satiety induction.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Sedivention

Frequently Asked Questions about Sedivention

When was Sedivention founded?

Sedivention was founded in 2021 and raised its 1st funding round 3 years after it was founded.

Where is Sedivention located?

Sedivention is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.

Who is the current CEO of Sedivention?

Ute Nollert is the current CEO of Sedivention. They have also founded this company.

Is Sedivention a funded company?

Sedivention is a funded company, having raised a total of $843.06K across 1 funding round to date. The company's 1st funding round was a Seed of $843.06K, raised on Nov 18, 2024.

What does Sedivention do?

Sedivention was founded in 2021 in Munich, Germany, focusing on medical devices in the health technology sector. A minimally invasive outpatient procedure using cryo-ablation is being developed to target the gastric branches of the vagus nerve, thereby reducing hunger signals for long-term weight management. The associated device has undergone testing for safety and efficacy, with backing from awards and investments in the European market.

Who are the top competitors of Sedivention?

Sedivention's top competitors include Allurion, Apollo Endo and GT Metabolic Solutions.

What products or services does Sedivention offer?

Sedivention offers Blizzard Catheter.

Who are Sedivention's investors?

Sedivention has 1 investor. Key investors include High-Tech Gründerfonds.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available